[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @AaronRosenblum5 Aaron Rosenblum, PhD, former CFA (fuck dues) Aaron Rosenblum, PhD, former CFA (fuck dues) posts on X about combo, $mrus, prob, mono the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1203443353339060225/interactions)  - X Week XXXXX -XX% - X Month XXXXXX +130% - X Months XXXXXXX +48% - X Year XXXXXXX +118% ### Mentions: XX [#](/creator/twitter::1203443353339060225/posts_active)  - X Week XX -XX% - X Month XX +69% - X Months XXX +6.20% - X Year XXX +143% ### Followers: XXXXX [#](/creator/twitter::1203443353339060225/followers)  - X Week XXXXX +0.67% - X Month XXXXX +21% - X Months XXXXX +44% - X Year XXXXX +66% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1203443353339060225/influencer_rank)  ### Social Influence [#](/creator/twitter::1203443353339060225/influence) --- **Social category influence** [stocks](/list/stocks) XXXX% [currencies](/list/currencies) XXXX% [cryptocurrencies](/list/cryptocurrencies) XXXX% [finance](/list/finance) XXXX% **Social topic influence** [combo](/topic/combo) 4.92%, [$mrus](/topic/$mrus) #11, [prob](/topic/prob) 3.28%, [mono](/topic/mono) 1.64%, [make a](/topic/make-a) 1.64%, [sig](/topic/sig) 1.64%, [prediction](/topic/prediction) 1.64%, [$vrtx](/topic/$vrtx) 1.64%, [vrtx](/topic/vrtx) 1.64%, [$gmab](/topic/$gmab) XXXX% **Top accounts mentioned or mentioned by** [@kingachillese](/creator/undefined) [@monacobiotech](/creator/undefined) [@richtrades100](/creator/undefined) [@biohazard3737](/creator/undefined) [@biomaven](/creator/undefined) [@monaco_biotech](/creator/undefined) [@sanctuarybio](/creator/undefined) [@clarksterh](/creator/undefined) [@seedy19tron](/creator/undefined) [@biotechsho99376](/creator/undefined) [@respekchemistry](/creator/undefined) [@orrdavid](/creator/undefined) [@biocamus](/creator/undefined) [@avidresearch](/creator/undefined) [@amaymd](/creator/undefined) [@wallstsai](/creator/undefined) [@houndcl](/creator/undefined) [@besterner](/creator/undefined) [@noserubinvest](/creator/undefined) [@adar170](/creator/undefined) **Top assets mentioned** [Merus N.V. Common Shares (MRUS)](/topic/$mrus) [Vertex Protocol (VRTX)](/topic/$vrtx) ### Top Social Posts [#](/creator/twitter::1203443353339060225/posts) --- Top posts by engagements in the last XX hours "@bioinvestor24 @jfais20 Amgen mono data was terrible. XXX mono was competitive with the best prmt5 data. Not sure we get registrational plans at this update but my guess would be they try with trodelvy in 2l uro and nsclc and maybe with their prmt5 as well" [X Link](https://x.com/AaronRosenblum5/status/1959343586979250337) [@AaronRosenblum5](/creator/x/AaronRosenblum5) 2025-08-23T19:54Z 2836 followers, XXX engagements "$mrus is pretty likely sig npv positive. I will go and make a bolder prediction mrus peak sales will exceed sgen peak sales. Wild how much Pfizer overpaid" [X Link](https://x.com/AaronRosenblum5/status/1972571583156994377) [@AaronRosenblum5](/creator/x/AaronRosenblum5) 2025-09-29T07:58Z 2836 followers, 3607 engagements "@monaco_biotech Are you actually bullish it will be differentiated and a commercial success or just think its a good bull market trade. I think the latter is def true but saw a recent post that its next mltx and I agree. Massive valuation for a me too" [X Link](https://x.com/AaronRosenblum5/status/1976182121971818512) [@AaronRosenblum5](/creator/x/AaronRosenblum5) 2025-10-09T07:05Z 2835 followers, XXX engagements "Is $vrtx dropping the heme side for pove" [X Link](https://x.com/AaronRosenblum5/status/1979173510300745949) [@AaronRosenblum5](/creator/x/AaronRosenblum5) 2025-10-17T13:11Z 2833 followers, 1876 engagements "@monaco_biotech XXXX isnt real. First there is the issue of the non evaluables and second on the XX evaluable post last data cut they went X pr X sd X pd with at least X response that failed to confirm. Still good data but claim doesnt hold up to the headline" [X Link](https://x.com/AaronRosenblum5/status/1979493010875314275) [@AaronRosenblum5](/creator/x/AaronRosenblum5) 2025-10-18T10:21Z 2837 followers, XXX engagements "@KingachillesE @monaco_biotech Prob a bit better than I was expecting. If true Orr was XX pyxs would deservedly trade down but not sure what happens now. Delaying combo data til mid26 is a bit of a red flag for me" [X Link](https://x.com/AaronRosenblum5/status/1979551635643809822) [@AaronRosenblum5](/creator/x/AaronRosenblum5) 2025-10-18T14:14Z 2837 followers, XXX engagements "@KingachillesE @monaco_biotech Maybe. My guess is raise priced at 35" [X Link](https://x.com/AaronRosenblum5/status/1979553171245515096) [@AaronRosenblum5](/creator/x/AaronRosenblum5) 2025-10-18T14:20Z 2837 followers, XX engagements "@KingachillesE @monaco_biotech If they want to run a XXX patient ph X like merus they prob need that much. If fund demand is strong enough I think they do but might be smaller" [X Link](https://x.com/AaronRosenblum5/status/1979555154845434267) [@AaronRosenblum5](/creator/x/AaronRosenblum5) 2025-10-18T14:28Z 2837 followers, XXX engagements "@TheBiotechBear I had assumed that mrus selling for 8b meant crc was a X. Getting plenary doesnt mean it will be a massive drug but also says its prob not a 0" [X Link](https://x.com/AaronRosenblum5/status/1977843287819161689) [@AaronRosenblum5](/creator/x/AaronRosenblum5) 2025-10-13T21:06Z 2837 followers, XXX engagements "@avidresearch @KingachillesE @monaco_biotech Disagree. 2l post egfr + pd1 could be a real market (unless another mmae adc such as pdl1v or Micvo beats peto). Combo more about efficacy and durability as not much overlapping tox imo" [X Link](https://x.com/AaronRosenblum5/status/1979560853763727848) [@AaronRosenblum5](/creator/x/AaronRosenblum5) 2025-10-18T14:51Z 2837 followers, XXX engagements "@avidresearch @KingachillesE @monaco_biotech Also their guide to start registrational mid XX but not show combo data til mid26 says they are planning 2l and tbd on 1l combo" [X Link](https://x.com/AaronRosenblum5/status/1979561374113268024) [@AaronRosenblum5](/creator/x/AaronRosenblum5) 2025-10-18T14:53Z 2837 followers, XXX engagements "@monaco_biotech Surprising nobody" [X Link](https://x.com/AaronRosenblum5/status/1980368504571457889) [@AaronRosenblum5](/creator/x/AaronRosenblum5) 2025-10-20T20:20Z 2838 followers, XXX engagements "If $mrus has a real drug in crc selling for 8b makes no sense at all" [X Link](https://x.com/AaronRosenblum5/status/1977837605564932554) [@AaronRosenblum5](/creator/x/AaronRosenblum5) 2025-10-13T20:43Z 2837 followers, 6563 engagements "@fbjb816 @btcbabey Way off. Looking a bit further back in your timeline unh long and vktx short were both good calls. Kinda silly the way you talk about clrb though (which is mostly what you have tweeted since I followed).Coming from someone very bullish pyxs a buyout is highly unrealistic" [X Link](https://x.com/AaronRosenblum5/status/1980427018744525236) [@AaronRosenblum5](/creator/x/AaronRosenblum5) 2025-10-21T00:12Z 2838 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Aaron Rosenblum, PhD, former CFA (fuck dues) posts on X about combo, $mrus, prob, mono the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks XXXX% currencies XXXX% cryptocurrencies XXXX% finance XXXX%
Social topic influence combo 4.92%, $mrus #11, prob 3.28%, mono 1.64%, make a 1.64%, sig 1.64%, prediction 1.64%, $vrtx 1.64%, vrtx 1.64%, $gmab XXXX%
Top accounts mentioned or mentioned by @kingachillese @monacobiotech @richtrades100 @biohazard3737 @biomaven @monaco_biotech @sanctuarybio @clarksterh @seedy19tron @biotechsho99376 @respekchemistry @orrdavid @biocamus @avidresearch @amaymd @wallstsai @houndcl @besterner @noserubinvest @adar170
Top assets mentioned Merus N.V. Common Shares (MRUS) Vertex Protocol (VRTX)
Top posts by engagements in the last XX hours
"@bioinvestor24 @jfais20 Amgen mono data was terrible. XXX mono was competitive with the best prmt5 data. Not sure we get registrational plans at this update but my guess would be they try with trodelvy in 2l uro and nsclc and maybe with their prmt5 as well"
X Link @AaronRosenblum5 2025-08-23T19:54Z 2836 followers, XXX engagements
"$mrus is pretty likely sig npv positive. I will go and make a bolder prediction mrus peak sales will exceed sgen peak sales. Wild how much Pfizer overpaid"
X Link @AaronRosenblum5 2025-09-29T07:58Z 2836 followers, 3607 engagements
"@monaco_biotech Are you actually bullish it will be differentiated and a commercial success or just think its a good bull market trade. I think the latter is def true but saw a recent post that its next mltx and I agree. Massive valuation for a me too"
X Link @AaronRosenblum5 2025-10-09T07:05Z 2835 followers, XXX engagements
"Is $vrtx dropping the heme side for pove"
X Link @AaronRosenblum5 2025-10-17T13:11Z 2833 followers, 1876 engagements
"@monaco_biotech XXXX isnt real. First there is the issue of the non evaluables and second on the XX evaluable post last data cut they went X pr X sd X pd with at least X response that failed to confirm. Still good data but claim doesnt hold up to the headline"
X Link @AaronRosenblum5 2025-10-18T10:21Z 2837 followers, XXX engagements
"@KingachillesE @monaco_biotech Prob a bit better than I was expecting. If true Orr was XX pyxs would deservedly trade down but not sure what happens now. Delaying combo data til mid26 is a bit of a red flag for me"
X Link @AaronRosenblum5 2025-10-18T14:14Z 2837 followers, XXX engagements
"@KingachillesE @monaco_biotech Maybe. My guess is raise priced at 35"
X Link @AaronRosenblum5 2025-10-18T14:20Z 2837 followers, XX engagements
"@KingachillesE @monaco_biotech If they want to run a XXX patient ph X like merus they prob need that much. If fund demand is strong enough I think they do but might be smaller"
X Link @AaronRosenblum5 2025-10-18T14:28Z 2837 followers, XXX engagements
"@TheBiotechBear I had assumed that mrus selling for 8b meant crc was a X. Getting plenary doesnt mean it will be a massive drug but also says its prob not a 0"
X Link @AaronRosenblum5 2025-10-13T21:06Z 2837 followers, XXX engagements
"@avidresearch @KingachillesE @monaco_biotech Disagree. 2l post egfr + pd1 could be a real market (unless another mmae adc such as pdl1v or Micvo beats peto). Combo more about efficacy and durability as not much overlapping tox imo"
X Link @AaronRosenblum5 2025-10-18T14:51Z 2837 followers, XXX engagements
"@avidresearch @KingachillesE @monaco_biotech Also their guide to start registrational mid XX but not show combo data til mid26 says they are planning 2l and tbd on 1l combo"
X Link @AaronRosenblum5 2025-10-18T14:53Z 2837 followers, XXX engagements
"@monaco_biotech Surprising nobody"
X Link @AaronRosenblum5 2025-10-20T20:20Z 2838 followers, XXX engagements
"If $mrus has a real drug in crc selling for 8b makes no sense at all"
X Link @AaronRosenblum5 2025-10-13T20:43Z 2837 followers, 6563 engagements
"@fbjb816 @btcbabey Way off. Looking a bit further back in your timeline unh long and vktx short were both good calls. Kinda silly the way you talk about clrb though (which is mostly what you have tweeted since I followed).Coming from someone very bullish pyxs a buyout is highly unrealistic"
X Link @AaronRosenblum5 2025-10-21T00:12Z 2838 followers, XXX engagements
/creator/x::AaronRosenblum5